Calgary, Alberta – TheNewswire - May 22, 2025 - Ocumetics Technology Corp . (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is pleased to announce the submission of its first-in-human (FIH) clinical study protocol for IRB approval. This development represents a critical step in the advancement of the Ocumetics Lens toward clinical trials planned for summer... Read More

Calgary, Alberta – TheNewswire - May 14, 2025 - Ocumetics Technology Corp . (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is pleased to announce it has successfully manufactured its inaugural accommodating intraocular lenses (the “Ocumetics Lens”) for use in its upcoming first-in-human (FIH) clinical study planned for summer 2025. Each Ocumetics Lens... Read More

Calgary, Alberta – TheNewswire - May 12 2025 - Ocumetics Technology Corp . (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is pleased to announce the successful completion of its optimized lens prototype design. With this milestone, Ocumetics has formally initiated a design freeze - locking in lens specifications that will be used in its upcoming... Read More

Calgary, Alberta – TheNewswire - May 8, 2025 - Ocumetics Technology Corp . (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is pleased to announce a significant breakthrough in its development of next-generation intraocular lens technology. In recent laboratory testing, the Company successfully demonstrated accommodative power change using 3D-printed moulded... Read More

Calgary, Alberta – TheNewswire - May 1, 2025 - Ocumetics Technology Corp. (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO) (the “ Corporation ” or “ Ocumetics ”) announces that Mr. Dayton Marks has resigned as a director of the Corporation. “On behalf of the Ocumetics board of directors, I would like to thank Dayton for his contributions to Ocumetics,” said Dr. Garth Webb, Ocumetics’ Founder and Chairman of the Board. “We are thankful... Read More

Calgary, Alberta – TheNewswire - April 22, 2025 - Ocumetics Technology Corp . (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is pleased to announce the achievement of several key milestones paving the way for its First-In-Human (“FIH”) clinical study of the Company’s innovative accommodating intraocular lens (the “Ocumetics Lens”). “Advancing a medical... Read More

Calgary, Alberta – TheNewswire - March 24, 2025 – Ocumetics Technology Corp. (“ Ocumetics ”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is pleased to announce that, subject to regulatory approval, it has engaged the services of Independent Trading Group ("ITG") to provide market-making services in accordance with TSX Venture Exchange “TSXV” policies. ITG will trade shares of Ocumetics... Read More

Calgary, Alberta – TheNewswire - March 11, 2025. Ocumetics Technology Corp. (“ Ocumetics” or the “Corporation” ) ( TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is pleased to announce that it has appointed Michael Edwards, BBA, CPA, CA, CLU, to its Board of Directors. “We are thrilled to have Michael join our board of directors,” says Dr. Garth Webb, founder and Chairman of Ocumetics.... Read More

Calgary, Alberta – TheNewswire - November 22, 2024 - Ocumetics Technology Corp. (“ Ocumetics” ) ( TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is pleased to provide an update on internal test results of its recently manufactured accommodative intraocular lenses (“ AIOL” ). During internal testing of lenses manufactured for its upcoming first in human (“ FIH ”) trials, the design team... Read More

Calgary, Alberta – TheNewswire - August 29, 2024 - Ocumetics Technology Corp. (“ Ocumetics ”) ( TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a pioneer in vision enhancement technology, is pleased to announce the successful fabrication of an intraocular lens (IOL) that is designed to respond to muscle activity that controls the curvature of the natural lens in the human eye. This achievement puts Ocumetics one step closer to the... Read More

Calgary, Alberta – TheNewswire - August 8, 2024 - Ocumetics Technology Corp. (“ Ocumetics ”) ( TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a pioneer in vision enhancement technology, is excited to announce the successful development of a new injector system specifically designed for implantation of the Ocumetics Accommodative Intraocular lens (the “Ocumetics Lens”). This achievement marks a significant milestone in Ocumetics’... Read More

Calgary, Alberta – TheNewswire - July 22, 2024 - Ocumetics Technology Corp. (“ Ocumetics ” or the “ Corporation ”) ( TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in vision enhancement technology, is pleased to announce that its intraocular lenses are now being manufactured for the upcoming first-in-human study in the Dominican Republic. “We are thrilled to collaborate with Bioana, leveraging their medical device expertise... Read More

Calgary, Alberta – June 21, 2024. - Th eNewswire - Ocumetics Technology Corp. (“ Ocumetics ” or the “ Corporation ”) ( TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO) announces that it has completed the second tranche of the private placement of debentures previously announced by the Corporation on May 15, 2024 and May 23, 2024. The Corporation has issued secured convertible debentures having an aggregate face value principal amount... Read More

Calgary, Alberta – May 24, 2024 - TheNewswire. Ocumetics Technology Corp. (“ Ocumetics ” or the “ Corporation ”) ( TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO) announces that it has completed the first tranche of the private placement of debentures previously announced by the Corporation on May 15, 2024. The Corporation has issued secured convertible debentures having an aggregate face value principal amount of $3,000,000 (the “... Read More

Calgary, Alberta – TheNewswire - May 15, 2024. Ocumetics Technology Corp. (“ Ocumetics ” or the “ Corporation ”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO) announces that it proposes to complete a non-brokered private placement of secured convertible debentures having an aggregate face value principal amount of up to $4,000,000 (the “ Principal ”). The debentures will be subject to an original issue discount of 6%, resulting in... Read More

Ocumetics Technology Corp. (“Ocumetics”) (TSXV:OTC) (OTC:OTCFF) (FRA:2QBO), is pleased to invite investors and other interested parties to attend an upcoming interview with Market Radius Research. Martin Gagel of Market Radius Research and CEO Dean Burns will be discussing Ocumetics’ revolutionary accommodating intraocular lens, the successful completion of animal studies and the upcoming First in Human study. The webinar... Read More

Calgary, Alberta – TheNewswire - January 17, 2024 - Ocumetics Technology Corp. (“ Ocumetics ” or the “ Corporation ”) ( TSXV:OTC) (OTC:OTCFF) (FRA:2QBO) announces that it has completed the private placement previously announced by the Corporation on November 15, 2023 and December 21, 2023. The Corporation issued an aggregate of 1,301,875 units (“ Units ”) pursuant to the private placement, at a price of $0.32, for total... Read More

Calgary, Alberta – TheNewswire - December 21, 2023 - Ocumetics Technology Corp. (“ Ocumetics ” or the “ Corporation ”) (TSXV:OTC) (OTC:OTCFF) (FRA:2QBO) is pleased to announce that the TSX Venture Exchange has granted a 15-day extension to close the Corporation’s non-brokered private placement announced on November 15, 2023. The new closing deadline for the private placement is January 15, 2024. The Corporation is proposing... Read More

Calgary, Alberta - TheNewswire - December 15, 2023. - Ocumetics Technology Corp. (“ Ocumetics ”) ( TSXV:OTC) (OTC:OTCFF) (FRA:2QBO) , a pioneer in the field of ophthalmic innovation, announces a webinar to discuss the successful completion of its biocompatibility animal study and its upcoming first-in-human study, anticipated to commence in Q1 2024 in the Dominican Republic. Dean Burns, CEO of Ocumetics and 27-year Alcon... Read More

Calgary, Alberta – TheNewswire - December 7, 2023 - Ocumetics Technology Corp. (“ Ocumetics ”) ( TSXV:OTC) (OTC:OTCFF) (FRA:2QBO), a pioneer in the field of ophthalmic innovation, proudly confirms the successful completion of its biocompatibility animal study, in preparation for its first-in-human study, anticipated to commence in Q1 2024 in the Dominican Republic. The biocompatibility of the Ocumetics accommodating... Read More

Calgary, Alberta – TheNewswire - November 15, 2023 - Ocumetics Technology Corp. (“ Ocumetics ” or the “ Corporation ”) ( TSXV:OTC) (OTC:OTCFF) (FRA:2QBO) announces that it proposes to complete a non-brokered private placement of up to 3,125,000 units of the Corporation (“ Units ”) at a price of $0.32 per Unit for gross proceeds of up to $1,000,000. There will be no minimum subscription level for this offering. Each Unit will... Read More

Calgary, Alberta – September 18, 2023. Ocum etics Technology Corp. (“ Ocumetics ”) ( TSXV:OTC) (OTC:OTCFF) (FRA:2QBO), a pioneer in in the field of ophthalmic innovation, proudly confirms a remarkable achievement in the optimization of its vision correction technology - the Ocumetics Accommodating Lens. Through rigorous research and development efforts over the past two years, Ocumetics has modified its lens design five... Read More

Calgary, Alberta – TheNewswire - September 1, 2023 - Ocumetics Technology Corp. (“ Ocumetics ” or the “ Corporation ”) ( TSXV:OTC) (OTC:OTCFF) (FRA:2QBO) a pioneer in advanced eye care solutions, is pleased to announce the appointment of Dr. Doyle Stulting and Dr. Bart McRoberts to its Board of Directors. With their unparalleled expertise in ophthalmology and vision research, Drs. Stulting and McRoberts bring a wealth of... Read More

Calgary, Alberta – TheNewswire - August 15, 2023. Ocumetics Technology Corp. (“ Ocumetics ” or the “ Corporation ”) ( TSXV:OTC) (OTC:OTCFF) (FRA:2QBO) announces that it has completed the private placement previously announced by the Corporation on June 22, 2023. The Corporation issued an aggregate of 3,333,333 units (“ Units ”) pursuant to the private placement, at a price of $0.30, for total gross proceeds of $1,000,000.... Read More

Calgary, Alberta – TheNewswire - July 25, 2023. Ocumetics Technology Corp. (“ Ocumetics ” or the “ Corporation ”) ( TSXV:OTC) (OTC:OTCFF) (FRA:2QBO) announces that it has completed the first tranche of the private placement previously announced by the Corporation on June 22, 2023. The Corporation has issued an aggregate of 1,880,868 units (“ Units ”) at a price of $0.30 per unit for aggregate gross proceeds of $564,260.40.... Read More

Calgary, Alberta – TheNewswire - June 22, 2023 - Ocumetics Technology Corp. (“ Ocumetics ” or the “ Corporation ”) ( TSXV:OTC) (OTC:OTCFF) (FRA:2QBO) announces that it proposes to complete a non-brokered private placement of up to 3,333,333 units of the Corporation (“ Units ”) at a price of $0.30 per Unit for gross proceeds of up to $1,000,000. There will be no minimum subscription level for this offering. Each Unit will... Read More

Calgary, Alberta – TheNewswire - June 20 , 2023 - Ocumetics Technology Corp. (TSXV:OTC) (OTC:OTCFF) (FRA:2QBO) (“ Ocumetics ” or the “ Company ”) is pleased to announce that the Company has reached a major milestone with the start of biocompatibility and animal studies for its updated lens design. As a result of extensive product testing and preliminary animal studies over the past 18 months, the Ocumetics research and... Read More

Dean Burns, a 27-year Alcon Vision veteran, will lead Ocumetics through the clinical trial and commercialization process Calgary, Alberta – TheNews wire - June 12 , 2023 - Ocumetics Technology Corp. (TSXV:OTC) (OTC:OTCFF) (FRA:2QBO) (“ Ocumetics ” or the “ Corporation ”) is pleased to announce that it has appointed Mr. Dean Burns as Ocumetics’ President and CEO. Mr. Burns will also join the Ocumetics board of directors. Mr.... Read More

Calgary, Alberta – TheNewswire - April 24, 2023. Ocumetics Technology Corp. (TSXV:OTC) (OTC:OTCFF) (FRA:2QBO) (the “ Corporation ” or “ Ocumetics ”) announces that Dr. Mark Lee has tendered his resignation as the Corporation’s President and Chief Executive Officer to take effect June 30, 2023. Dr. Lee will continue as the Corporation’s President and Chief Executive Officer until June 30, 2023 as the Corporation seeks to hire... Read More

Calgary, Alberta – TheNewswire - April 19, 2023 - Ocumetics Technology Corp. (“ Ocumetics ” or the “ Company ”) ( TSXV:OTC) (OTC:OTCFF) (FRA:2QBO) is pleased to announce that its research and development team has successfully completed design lockdown for the Ocumetics accommodating lens that will move into the next stage of testing. “This announcement represents the completion of thousands of hours of design work and bench... Read More

Calgary, AB - TheNewswire - February 13, 2023 - Ocumetics Technology Corp. (“ Ocumetics ” or the “ Company ”) ( TSXV:OTC) (OTC:OTCFF) (FRA:2QBO) is pleased to announce the successful completion of its latest animal studies. “The purpose of these studies was to test our latest design,” said Dr. Garth Webb, Ocumetics’ Founder and Chief Scientific Officer. “The lens design met and exceeded our expectations. It is exciting to... Read More

Calgary, Alberta – TheNewswire – February 1, 2023 - Ocumetics Technology Corp. (“ Ocumetics ” or the “ Corporation ”) ( TSXV:OTC) (OTC:OTCFF) (FRA:2QBO) announces that it has completed a private placement of 1,493,574 units of the Corporation (“ Units ”) at a price of $0.45 per Unit for gross proceeds of $672,108.15. Each Unit consists of one common share in the share capital of the Corporation (“ Common Share ”) and... Read More